mhurhangee/ep-ind-claims huggingface dataset:
A process for the production of substitute natural gas comprising: providing a feed gas to a first (2, 32) and/or second (3, 33) and/or subsequent bulk methanator; subjecting that feed gas to methanation in the presence of a suitable catalyst; removing an at least partially reacted stream from the first bulk methanator (2, 32) and supplying it to the second (3, 33) and/or subsequent bulk methanator where it is subjected to further methanation; passing a product stream from the final bulk methanator to a trim methanator train (9, 39) where it is subjected to further methanation; removing a recycle stream downstream of the first, second or subsequent bulk methanator, and, in any order, passing it through a compressor (13, 43), subjecting it to cooling and then supplying to a trim and/or recycle methanator (17, 47) for further methanation before being recycled to the first and/or second and/or subsequent methanator. providing a feed gas to a first (2, 32) and/or second (3, 33) and/or subsequent bulk methanator; subjecting that feed gas to methanation in the presence of a suitable catalyst; removing an at least partially reacted stream from the first bulk methanator (2, 32) and supplying it to the second (3, 33) and/or subsequent bulk methanator where it is subjected to further methanation; passing a product stream from the final bulk methanator to a trim methanator train (9, 39) where it is subjected to further methanation;
A method for producing a building material characterized as an inorganic material containing a woody reinforement, comprising: a first step of applying a first ultraviolet-curable paint onto an inorganic material containing a woody reinforcement and incompletely curing the first ultraviolet-curable paint; a second step of applying a second ultraviolet-curable paint and completely curing the second ultraviolet-curable paint; a third step of polishing the completely cured second ultraviolet-curable paint to smoothen a surface of the completely cured second ultraviolet-curable paint; and a fourth step of applying an enamel paint and curing the enamel paint, wherein in the second step, a paint containing 40 to 70 mass% of a filler in terms of solid content is applied as the second ultraviolet-curable paint while the first ultraviolet-curable paint is incompletely cured. a first step of applying a first ultraviolet-curable paint onto an inorganic material containing a woody reinforcement and incompletely curing the first ultraviolet-curable paint; a second step of applying a second ultraviolet-curable paint and completely curing the second ultraviolet-curable paint; a third step of polishing the completely cured second ultraviolet-curable paint to smoothen a surface of the completely cured second ultraviolet-curable paint; and a fourth step of applying an enamel paint and curing the enamel paint, wherein in the second step, a paint containing 40 to 70 mass% of a filler in terms of solid content is applied as the second ultraviolet-curable paint while the first ultraviolet-curable paint is incompletely cured.
A field-effect transistor, comprising: a gate electrode; a source electrode and a drain electrode; an active layer formed of a n-type oxide semiconductor, provided in contact with the source electrode and the drain electrode; and a gate insulating layer provided between the gate electrode and the active layer, wherein the n-type oxide semiconductor is a monoclinic crystal compound, which is substitutionally doped with at least one dopant selected from the group consisting of a divalent cation, a trivalent cation, a tetravalent cation, a pentavalent cation, and a hexavalent cation, and wherein a valence of the dopant is greater than a valence of a metal ion constituting the n-type oxide semiconductor, excluding the dopant, wherein the monoclinic crystal compound belongs to the point group C 2 or Cs, and the substitutional doping is performed by introduction of a cation of at least one selected from the group consisting of Mg, Zr, Bi, Mo, and Te, wherein the monoclinic crystal compound belongs to any one of the space groups No. 3 to No. 9, and wherein the monoclinic crystal compound contains at least one cation selected from the group consist of Li, Sr, Ge, Pb, Bi, Nb, and W as a cation other than the dopant. a gate electrode; a source electrode and a drain electrode; an active layer formed of a n-type oxide semiconductor, provided in contact with the source electrode and the drain electrode; and a gate insulating layer provided between the gate electrode and the active layer, wherein the n-type oxide semiconductor is a monoclinic crystal compound, which is substitutionally doped with at least one dopant selected from the group consisting of a divalent cation, a trivalent cation, a tetravalent cation, a pentavalent cation, and a hexavalent cation, and wherein a valence of the dopant is greater than a valence of a metal ion constituting the n-type oxide semiconductor, excluding the dopant, wherein the monoclinic crystal compound belongs to the point group C 2 or Cs, and the substitutional doping is performed by introduction of a cation of at least one selected from the group consisting of Mg, Zr, Bi, Mo, and Te, wherein the monoclinic crystal compound belongs to any one of the space groups No. 3 to No. 9, and wherein the monoclinic crystal compound contains at least one cation selected from the group consist of Li, Sr, Ge, Pb, Bi, Nb, and W as a cation other than the dopant.
Light module (10, 50, 60, 80, 90) for motor vehicle headlamps, comprising: at least one laser light source (12, 12a, 12b) for emitting a primary light pencil in a primary solid angle range about a primary beam axis; a photoluminescent element which is arranged in such a way that the primary light pencil that can be emitted by means of the laser light source hits the photoluminescent element, and which is designed in such a way that a secondary light distribution can be emitted as a result of the incident primary light pencil by utilizing photoluminescence; an emission optical device which is designed in such a way that the secondary light distribution can be converted into an emission light distribution of the light module; at least one detection device (34, 34a, 34b) which is designed and arranged in such a way that it is possible to detect when the radiation intensity of light pencils that extend in the beam path downstream of the photoluminescent element in the primary solid angle range about the primary beam axis exceeds a safety limit, the detection device being designed to measure the radiation intensity of light pencils that extend in the primary solid angle range about the primary beam axis, characterized in that a reference detection device is provided which is designed and arranged such that it is possible to measure a reference radiation intensity of the secondary light distribution outside the primary solid angle range about the primary beam axis.
A filter arrangement comprising an inlet and an outlet, the filter arrangement further comprising a chamber and a plurality of elongate hollow filtration elements contained therein, each element comprising a semi-permeable filtration wall and an internally located back-washing mechanism; wherein the chamber is generally cylindrical and the plurality of hollow filtration elements are arranged parallel to the elongate axis of the cylindrical chamber; and wherein the plurality of hollow filtration elements are equally spaced within and around the periphery of the chamber, wherein each back-washing mechanism comprises at least one debris receiving portion having a cross-section corresponding to the cross-section of the hollow filtration element such that the outer perimeter of the debris receiving portion is located immediately adjacent to the inner periphery of the filtration wall of the hollow element; wherein the plurality of peripherally located filtration elements define a centrally located space having a radius measured radially from the central axis of the filter arrangement to a proximate surface of one of the peripherally located elements; wherein the radius of said centrally located space is equal to or less than the radius of said outlet of said filter arrangement; and wherein said inlet and said outlet are coaxial with each other and parallel with the axes of the chamber and filtration elements.
A fluid ejection device, comprising: a substrate (120; 120') having a fluid channel, wherein the fluid channel includes a fluid inlet, a fluid plenum communicated with the fluid inlet, a fluid ejection chamber communicated with the fluid plenum, a fluid outlet communicated with the fluid ejection chamber and a constriction between the fluid plenum and the fluid ejection chamber; a flexible membrane supported by the substrate and extended a length of the fluid channel, wherein the constriction supports the flexible membrane between a first portion and a second portion of the flexible membrane; an actuator provided on the first portion of the flexible membrane, wherein the actuator is adapted to deflect the first portion of the flexible membrane relative to the fluid channel; a reinforcement member provided on the second portion of the flexible membrane, wherein the reinforcement member supports the second portion of the flexible membrane. a substrate (120; 120') having a fluid channel, wherein the fluid channel includes a fluid inlet, a fluid plenum communicated with the fluid inlet, a fluid ejection chamber communicated with the fluid plenum, a fluid outlet communicated with the fluid ejection chamber and a constriction between the fluid plenum and the fluid ejection chamber; a flexible membrane supported by the substrate and extended a length of the fluid channel, wherein the constriction supports the flexible membrane between a first portion and a second portion of the flexible membrane; an actuator provided on the first portion of the flexible membrane, wherein the actuator is adapted to deflect the first portion of the flexible membrane relative to the fluid channel; a reinforcement member provided on the second portion of the flexible membrane, wherein the reinforcement member supports the second portion of the flexible membrane.
An assembly of an encased nut and a body comprising: a case body which is welded to the body; and a nut which is freely movably held inside the case body, characterized in that: the nut is composed of a nut body and an insulating member which is made of a resin and insert-molded on the outer surface of the nut body; and the insulating member is provided with a resin head part and a resin flange part having a plurality of protrusions on the side, abutting on the body, of an outer circumferential part of the resin flange part; and the resin head part is freely movably inserted into a guide hole formed in the body. a case body which is welded to the body; and a nut which is freely movably held inside the case body, characterized in that: the nut is composed of a nut body and an insulating member which is made of a resin and insert-molded on the outer surface of the nut body; and the insulating member is provided with a resin head part and a resin flange part having a plurality of protrusions on the side, abutting on the body, of an outer circumferential part of the resin flange part; and the resin head part is freely movably inserted into a guide hole formed in the body. the nut is composed of a nut body and an insulating member which is made of a resin and insert-molded on the outer surface of the nut body; and the insulating member is provided with a resin head part and a resin flange part having a plurality of protrusions on the side, abutting on the body, of an outer circumferential part of the resin flange part; and the resin head part is freely movably inserted into a guide hole formed in the body.
An injectable pharmaceutical composition comprising: water; one or more water soluble complexes, each comprising 2-hydroxypropyl-β-cyclodextrin and alfaxalone; optionally a buffer effective to provide a pH in the composition in a range of from 4.0 to 9.0; at least one preservative, wherein at the least one preservative is selected from the group consisting of: methylparaben, ethylparaben, propylparaben, butylparaben, or their salts, or benzethonium chloride in an amount in a range of 0.005 to 1 % w/v; m-cresol, or chlorocresol, in an amount in a range of 0.1 to 1 % w/v; phenylethanol or phenoxyethanol in an amount in a range of 0.1 to 1 % w/v; chlorobutanol or phenol in an amount in a range of 0.05 to 1 % w/v; boric acid, in an amount in a range of 0.25 to 5 % w/v; benzyl alcohol in an amount in a range of 0.1 to 5 % w/v; benzalkonium chloride in an amount in a range of 0.001 to 1% w/v; and mixtures thereof; and at least one co-solvent in an amount in a range of 1 to 30 % w/v selected from the group consisting of ethanol, glycerin, isopropyl alcohol, polyethylene glycol and mixtures thereof. water; one or more water soluble complexes, each comprising 2-hydroxypropyl-β-cyclodextrin and alfaxalone; optionally a buffer effective to provide a pH in the composition in a range of from 4.0 to 9.0; at least one preservative, wherein at the least one preservative is selected from the group consisting of: methylparaben, ethylparaben, propylparaben, butylparaben, or their salts, or benzethonium chloride in an amount in a range of 0.005 to 1 % w/v; m-cresol, or chlorocresol, in an amount in a range of 0.1 to 1 % w/v; phenylethanol or phenoxyethanol in an amount in a range of 0.1 to 1 % w/v; chlorobutanol or phenol in an amount in a range of 0.05 to 1 % w/v; boric acid, in an amount in a range of 0.25 to 5 % w/v; benzyl alcohol in an amount in a range of 0.1 to 5 % w/v; benzalkonium chloride in an amount in a range of 0.001 to 1% w/v; and mixtures thereof; and at least one co-solvent in an amount in a range of 1 to 30 % w/v selected from the group consisting of ethanol, glycerin, isopropyl alcohol, polyethylene glycol and mixtures thereof. methylparaben, ethylparaben, propylparaben, butylparaben, or their salts, or benzethonium chloride in an amount in a range of 0.005 to 1 % w/v; m-cresol, or chlorocresol, in an amount in a range of 0.1 to 1 % w/v; phenylethanol or phenoxyethanol in an amount in a range of 0.1 to 1 % w/v; chlorobutanol or phenol in an amount in a range of 0.05 to 1 % w/v; boric acid, in an amount in a range of 0.25 to 5 % w/v; benzyl alcohol in an amount in a range of 0.1 to 5 % w/v; benzalkonium chloride in an amount in a range of 0.001 to 1% w/v; and mixtures thereof; and at least one co-solvent in an amount in a range of 1 to 30 % w/v selected from the group consisting of ethanol, glycerin, isopropyl alcohol, polyethylene glycol and mixtures thereof.
Process for producing superacid-acidified, in particular trifluoromethanesulfonic acid-acidified, (end-)equilibrated linear α,ω-acetoxy-bearing siloxanes, characterized in that (i) linear α,ω-hydroxy-bearing siloxanes, (ii) using superacid, particularly preferably perfluoroalkanesulfonic acid, especially preferably trifluoromethanesulfonic acid, as catalyst, (iii) are reacted with acetic anhydride and with addition of acetic acid. (i) linear α,ω-hydroxy-bearing siloxanes, (ii) using superacid, particularly preferably perfluoroalkanesulfonic acid, especially preferably trifluoromethanesulfonic acid, as catalyst, (iii) are reacted with acetic anhydride and with addition of acetic acid.
A shoe cover cartridge for an automatic shoe cover dispenser which has a cartridge cavity and a shoe disposing opening, comprising: a guiding unit for detachably receiving in said shoe cover dispenser; a plurality of shoe covers overlapped with each other in a sequential manner that one of said shoe covers is pulled into an open-up condition as a standby shoe cover and a subsequent shoe cover followed by said standby shoe cover; and an interlocking arrangement for detachably coupling said shoe covers at said guiding unit, wherein said interlocking arrangement comprises a front interlocking provided at a front side of each of said shoe covers, and a rear interlocking unit provided at a rear side of each of said shoe covers, wherein said front and rear interlocking units (321,331) are slidably engaged with said guiding unit at a position that said front interlocking unit at said subsequent shoe cover is located in front of said rear interlocking unit at said standby shoe cover, such that when said standby shoe cover is pulled to said shoe disposing opening, said subsequent shoe is pulled by said standby shoe cover from said cartridge cavity, so as to dispense said shoe covers in a sequential order. a guiding unit for detachably receiving in said shoe cover dispenser; a plurality of shoe covers overlapped with each other in a sequential manner that one of said shoe covers is pulled into an open-up condition as a standby shoe cover and a subsequent shoe cover followed by said standby shoe cover; and an interlocking arrangement for detachably coupling said shoe covers at said guiding unit, wherein said interlocking arrangement comprises a front interlocking provided at a front side of each of said shoe covers, and a rear interlocking unit provided at a rear side of each of said shoe covers, wherein said front and rear interlocking units (321,331) are slidably engaged with said guiding unit at a position that said front interlocking unit at said subsequent shoe cover is located in front of said rear interlocking unit at said standby shoe cover, such that when said standby shoe cover is pulled to said shoe disposing opening, said subsequent shoe is pulled by said standby shoe cover from said cartridge cavity, so as to dispense said shoe covers in a sequential order.
An apparatus comprising: a switch configured to control an electrical connection between a charging device and a power source, wherein a current flows from the power source through the charging device to a battery to charge the battery when the electrical connection is present between the charging device and the power source; a charging management module configured to: identify a period of time for charging the battery; control the switch to electrically connect the charging device to the power source during the identified period of time for charging the battery; and, characterized in that the apparatus comprises: a sensor configured to measure the current at a location between the power source and the switch to form current information, wherein the charging management module is configured to use the current information to identify a charging profile for the battery that identifies a voltage at which the charging device reduces a flow of the current to the battery. a switch configured to control an electrical connection between a charging device and a power source, wherein a current flows from the power source through the charging device to a battery to charge the battery when the electrical connection is present between the charging device and the power source; a charging management module configured to: identify a period of time for charging the battery; control the switch to electrically connect the charging device to the power source during the identified period of time for charging the battery; and, characterized in that the apparatus comprises: a sensor configured to measure the current at a location between the power source and the switch to form current information, wherein the charging management module is configured to use the current information to identify a charging profile for the battery that identifies a voltage at which the charging device reduces a flow of the current to the battery.
One or more SGLT-2 inhibitors or pharmaceutically acceptable crystalline forms thereof for use in the treatment and/or prevention of a metabolic disorder in a feline animal in need of such treatment and/or prevention, wherein the metabolic disorder is one or more selected from the group consisting of ketoacidosis, pre-diabetes, diabetes mellitus type 1 or type 2, insulin resistance, obesity, hyperglycemia, impaired glucose tolerance, hyperinsulinemia, dyslipidemia, dysadipokinemia, subclinical inflammation, systemic inflammation, low grade systemic inflammation, hepatic lipidosis, atherosclerosis, inflammation of the pancreas, and/or Syndrome X (metabolic syndrome) and/or loss of pancreatic beta cell function and wherein the one or more SGLT-2 inhibitors are to be administered at a dose of 0.1 to 5.0 mg/kg body mass per day.
Container closure system containing an overpouch with an intransparent first foil and a transparent second foil, a transparent primary container, preferably a bag, for holding a transparent pharmaceutical solution, wherein the transparent primary container is packed within the overpouch between the first and the second foils, and labeled with at least one label and, characterized in that the at least one label acts as a light absorbing segment having a reflection R L for light in the range of 350 nm to 800 nm and an inner surface of the intransparent first foil of the overpouch acts as a light reflecting background having a reflection R F for light in the direction of the primary container in the range of 350 nm to 800 nm with R F > R L or the at least one label acts as a light reflecting segment having a reflection R L for light in the range of 350 nm to 800 nm and an inner surface of the intransparent first foil of the overpouch acts as a light absorbing background having a reflection R F for light in the direction of the primary container in the range of 350 nm to 800 nm with R L > R F.